Semaglutide is a common type of GLP-1 drug
10.1021/acschemneuro.4c00620 65 LiangD.FengY.ZandkarimiF.WangH.ZhangZ.KimJ.et al (2023)
Injectable anti-aging protocol: Dose: 1-2mg daily Frequency: 5 days on, 2 days off OR daily for 30 days Cycle: 30 days on, 14 days off Duration: Minimum 2-3 cycles for substantial results Topical anti-aging protocol: Concentration: 2-3% serum or cream Application: Twice daily (morning and evening) Duration: 12+ weeks continuous use Combine with: Sunscreen (always), retinoids (evening, separate application) Combination approach: Maximum anti-aging results come from combining injectable and topical
Book a consultation online or call us at (319) 258-5424
These sensations are typically mild and temporary as the body adjusts

This guide covers: How GLP-1 medications work and why their effects extend beyond glucose Blood sugar control: what results to expect Weight loss: magnitude and timeline Cardiovascular benefits: the evidence and what it means Kidney and liver protection Comparing different GLP-1 medications (semaglutide, tirzepatide, liraglutide, dulaglutide) How GLP-1s fit with other diabetes treatments Who benefits most from these medications Practical considerations for access and cost Key Takeaways GLP-1 medications produce comprehensive metabolic improvement , addressing blood sugar, weight, cardiovascular risk, and organ health simultaneously HbA1c reductions average 1.0-2.0 percentage points , with many patients achieving target levels under 7% Weight loss averages 10-15% with semaglutide , substantially more than older diabetes medications Cardiovascular event reduction of 20% has been demonstrated in high-risk patients, making GLP-1s the preferred choice for patients with heart disease Kidney protection extends beyond what glucose control alone would provide Tirzepatide (dual GLP-1/GIP agonist) produces greater improvements than single-mechanism GLP-1 agonists These medications can reduce or eliminate the need for other diabetes drugs , including insulin in many cases Side effects are primarily gastrointestinal and usually improve with time and proper titration Cost remains a barrier , though compounded options and manufacturer programs improve access GLP-1 medications are now recommended as first-line treatment for many Type 2 diabetes patients, particularly those with cardiovascular disease or obesity Understanding GLP-1 Medications Before exploring their benefits, understanding how these medications work explains why they affect so many aspects of metabolic health
